EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multiomic characterization of disease progression in mice lacking dystrophin

Mirko Signorelli iD, Roula Tsonaka, Annemieke Aartsma-Rus iD, Pietro Spitali iD

PLOS ONE · 31.03.2023 · 18 (3) · e0283869

DOI: 10.1371/journal.pone.0283869 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 31.03.2023. Verfasst von Mirko Signorelli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mathematical Institute, Leiden University, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Dystrophin, Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Duchenne Parent Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Duchenne muscular dystrophy (DMD) is caused by genetic mutations leading to lack of dystrophin in skeletal muscle. A better understanding of how objective biomarkers for DMD vary across subjects and over time is needed to model disease progression and response to therapy more effectively, both in pre-clinical and clinical research. We present an in-depth characterization of disease progression in 3 murine models of DMD by multiomic analysis of longitudinal trajectories between 6 and 30 weeks of age. Integration of RNA-seq, mass spectrometry-based metabolomic and lipidomic data obtained in muscle and blood samples by Multi-Omics Factor Analysis (MOFA) led to the identification of 8 latent factors that explained 78.8% of the variance in the multiomic dataset. Latent factors could discriminate dystrophic and healthy mice, as well as different time-points. MOFA enabled to connect the gene expression signature in dystrophic muscles, characterized by pro-fibrotic and energy metabolism alterations, to inflammation and lipid signatures in blood. Our results show that omic observations in blood can be directly related to skeletal muscle pathology in dystrophic muscle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DystrophinMuscular Dystrophy, DuchenneMiceAnimalsMice, Inbred mdxMultiomicsMuscle, SkeletalDisease ProgressionDisease Models, Animal

Substanzen

Dystrophin

Autor:innen und Institutionen

  • Mathematical Institute, Leiden University, Leiden, The Netherlands.
  • Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.

ORCID-Profile: Mirko Signorelli, Annemieke Aartsma-Rus, Pietro Spitali

Förderung

  • Duchenne Parent Project

Zitieren

APA

Signorelli, M., Tsonaka, R., Aartsma-Rus, A., & Spitali, P. (2023). Multiomic characterization of disease progression in mice lacking dystrophin. PLOS ONE, 18(3), e0283869. https://doi.org/10.1371/journal.pone.0283869

Vancouver

Signorelli M, Tsonaka R, Aartsma-Rus A, Spitali P. Multiomic characterization of disease progression in mice lacking dystrophin. PLOS ONE. 2023;18(3):e0283869. doi:10.1371/journal.pone.0283869

BibTeX
@article{Signorelli2023,
  author = {Signorelli, Mirko and Tsonaka, Roula and Aartsma-Rus, Annemieke and Spitali, Pietro},
  title = {Multiomic characterization of disease progression in mice lacking dystrophin},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {3},
  pages = {e0283869},
  doi = {10.1371/journal.pone.0283869}
}
Kostenlos starten →